PolyPid Change in Accounts Payable 2019-2025 | PYPD

PolyPid change in accounts payable from 2019 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.

PolyPid Change in Accounts Payable 2019-2025 | PYPD

PolyPid change in accounts payable from 2019 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$82.5B
Zoetis (ZTS)$65B
Daiichi Sankyo, - (DSNKY)$47.2B
Takeda Pharmaceutical (TAK)$45.4B
BeOne Medicines - (ONC)$32.7B
Sandoz Group AG (SDZNY)$24.6B
Summit Therapeutics (SMMT)$21.2B
Merck (MKKGY)$16B
Shionogi (SGIOY)$15.1B
United Therapeutics (UTHR)$13.6B
Neurocrine Biosciences (NBIX)$12.7B
Orion OYJ (ORINY)$11.7B
IPSEN (IPSEY)$10.1B
Madrigal Pharmaceuticals (MDGL)$7.5B
Corcept Therapeutics (CORT)$7.4B
Stevanato Group S.p.A (STVN)$7.3B
Grifols, S.A (GRFS)$7.2B
Ionis Pharmaceuticals (IONS)$6.5B
Hikma Pharmaceuticals Plc (HKMPF)$5.9B
Ono Pharmaceutical (OPHLF)$5.2B
Soleno Therapeutics (SLNO)$4.1B
Hypermarcas (HYPMY)$2.8B
Crinetics Pharmaceuticals (CRNX)$2.7B
Catalyst Pharmaceuticals (CPRX)$2.7B
NewAmsterdam Pharma (NAMS)$2.7B
Procaps Group, S.A (PROCF)$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.5B
Centessa Pharmaceuticals (CNTA)$2.3B
Ocular Therapeutix (OCUL)$2.2B
Endo (NDOI)$1.8B